Oracle Recognized as a Leader in Everest Group PEAK Matrix® for Life Sciences Clinical Trial Management System (CTMS) Assessment 2024
Oracle Life Sciences has been named a 'Leader' in the Everest Group Life Sciences Clinical Trial Management System (CTMS) PEAK Matrix® Assessment 2024. This recognition highlights Oracle's commitment to transforming clinical trial management through innovative solutions.
Oracle's Siebel CTMS platform enables seamless integration with Electronic Health Records (EHR), Electronic Data Capture (EDC), and other critical systems while ensuring regulatory compliance. The platform offers comprehensive trial data management capabilities with flexibility for customization to meet specific organizational needs.
The assessment emphasizes Oracle's strengths in providing cost-effective solutions, global adaptability, and extensive integration capabilities with various clinical systems including CDMS, eTMF, payment, analytics, and regulatory systems. The evaluation was based on the Everest Group PEAK Matrix® framework, which assesses providers on market success and delivery capabilities, including revenue, client base, growth, operations scale, technology innovation, and buyer satisfaction.
Oracle Life Sciences è stata nominata 'Leader' nella Valutazione PEAK Matrix® 2024 dei Sistemi di Gestione delle Sperimentazioni Cliniche (CTMS) del Everest Group. Questo riconoscimento evidenzia l'impegno di Oracle nel trasformare la gestione delle sperimentazioni cliniche attraverso soluzioni innovative.
La piattaforma Siebel CTMS di Oracle consente un'integrazione fluida con i Registri Sanitari Elettronici (EHR), la Cattura Dati Elettronica (EDC) e altri sistemi critici, garantendo al contempo la conformità normativa. La piattaforma offre capacità complete di gestione dei dati delle sperimentazioni con flessibilità per la personalizzazione in base alle esigenze specifiche delle organizzazioni.
La valutazione sottolinea i punti di forza di Oracle nella fornitura di soluzioni economicamente vantaggiose, nella capacità di adattarsi a livello globale e nelle ampie capacità di integrazione con vari sistemi clinici, tra cui CDMS, eTMF, pagamenti, analisi e sistemi normativi. La valutazione si basa sul framework PEAK Matrix® del Everest Group, che valuta i fornitori in base al successo di mercato e alle capacità di erogazione, inclusi fatturato, base clienti, crescita, scala operativa, innovazione tecnologica e soddisfazione degli acquirenti.
Oracle Life Sciences ha sido nombrada 'Líder' en la Evaluación PEAK Matrix® 2024 de Sistemas de Gestión de Ensayos Clínicos (CTMS) del Everest Group. Este reconocimiento resalta el compromiso de Oracle con la transformación de la gestión de ensayos clínicos a través de soluciones innovadoras.
La plataforma Siebel CTMS de Oracle permite la integración sin problemas con los Registros Electrónicos de Salud (EHR), la Captura Electrónica de Datos (EDC) y otros sistemas críticos, al tiempo que garantiza el cumplimiento normativo. La plataforma ofrece capacidades integrales de gestión de datos de ensayos con flexibilidad para personalización según las necesidades específicas de las organizaciones.
La evaluación destaca las fortalezas de Oracle en la provisión de soluciones rentables, su adaptabilidad global y amplias capacidades de integración con diversos sistemas clínicos, incluidos CDMS, eTMF, pagos, análisis y sistemas regulatorios. La evaluación se basó en el marco PEAK Matrix® del Everest Group, que evalúa a los proveedores en función del éxito en el mercado y las capacidades de entrega, que incluyen ingresos, base de clientes, crecimiento, escala operativa, innovación tecnológica y satisfacción del comprador.
오라클 생명과학은 에버레스트 그룹 생명과학 임상 시험 관리 시스템(CTMS) PEAK 매트릭스 2024 평가에서 '리더'로 선정되었습니다. 이 인정은 혁신적인 솔루션을 통해 임상 시험 관리의 변화를 이끌고자 하는 오라클의 헌신을 강조합니다.
오라클의 Siebel CTMS 플랫폼은 전자 건강 기록(EHR), 전자 데이터 캡처(EDC) 및 기타 중요한 시스템과의 원활한 통합을 지원하며 규제 준수를 보장합니다. 이 플랫폼은 특정 조직의 요구를 충족하기 위해 사용자 정의할 수 있는 유연성을 갖춘 포괄적인 시험 데이터 관리 기능을 제공합니다.
평가는 다양한 임상 시스템(CDMS, eTMF, 지불, 분석 및 규제 시스템 포함)과의 비용 효율적인 솔루션 제공, 글로벌 적응성 및 광범위한 통합 역량에서 오라클의 강점을 강조합니다. 평가는 시장 성공 및 제공 능력, 수익, 고객 기반, 성장, 운영 규모, 기술 혁신 및 구매자 만족도를 포함하여 공급자를 평가하는 에버레스트 그룹 PEAK 매트릭스 프레임워크를 기반으로 합니다.
Oracle Life Sciences a été désignée 'Leader' dans l'Évaluation PEAK Matrix® 2024 des Systèmes de Gestion des Essais Cliniques (CTMS) du Everest Group. Cette reconnaissance met en avant l'engagement d'Oracle à transformer la gestion des essais cliniques grâce à des solutions innovantes.
La plateforme Siebel CTMS d'Oracle permet une intégration fluide avec les Dossiers de Santé Électroniques (EHR), la Capture de Données Électroniques (EDC) et d'autres systèmes critiques tout en garantissant la conformité réglementaire. La plateforme offre des capacités complètes de gestion des données d'essai avec une flexibilité de personnalisation pour répondre aux besoins spécifiques des organisations.
L'évaluation souligne les forces d'Oracle en matière de solutions rentables, d'adaptabilité mondiale et de capacités d'intégration étendues avec divers systèmes cliniques, y compris CDMS, eTMF, paiements, analyses et systèmes réglementaires. L'évaluation était basée sur le cadre PEAK Matrix® de l'Everest Group, qui évalue les fournisseurs sur le succès du marché et les capacités de livraison, y compris les revenus, la base de clients, la croissance, l'échelle des opérations, l'innovation technologique et la satisfaction des acheteurs.
Oracle Life Sciences wurde als 'Leader' in der Everest Group Life Sciences Clinical Trial Management System (CTMS) PEAK Matrix® Assessment 2024 ausgezeichnet. Diese Anerkennung hebt das Engagement von Oracle hervor, das Management klinischer Studien durch innovative Lösungen zu transformieren.
Die Siebel CTMS-Plattform von Oracle ermöglicht eine nahtlose Integration mit Elektronischen Gesundheitsakten (EHR), Elektronischer Datenerfassung (EDC) und anderen kritischen Systemen, während die Einhaltung gesetzlicher Vorschriften gewährleistet wird. Die Plattform bietet umfassende Datenmanagement-Funktionen für Studien mit Flexibilität zur Anpassung an spezifische organisatorische Anforderungen.
Die Bewertung betont die Stärken von Oracle in der Bereitstellung kosteneffektiver Lösungen, globaler Anpassungsfähigkeit und umfangreicher Integrationsmöglichkeiten mit verschiedenen klinischen Systemen, darunter CDMS, eTMF, Zahlungs-, Analyse- und Regulierungs-systeme. Die Bewertung basierte auf dem PEAK Matrix®-Rahmenwerk der Everest Group, das Anbieter anhand von Markterfolg und Leistungsvermögen, einschließlich Umsatz, Kundenbasis, Wachstum, Betriebsskalierung, technologischem Innovationsgrad und Käuferzufriedenheit, bewertet.
- None.
- None.
Highlights ease of deployment, value, and extensibility of comprehensive Oracle platform
As the life sciences industry evolves, driven by increasing trial complexities, regulatory demands, and the need for real-time insights, Oracle continues to redefine the industry standard for CTMS platforms. Oracle's Siebel CTMS platform enables integration with Electronic Health Records (EHR) for seamless data flow between investigators, Contract Research Organizations (CROs), and sponsors, integration with Electronic Data Capture (EDC), and other critical systems, and adherence to diverse regulatory standards.
"Being designated as a 'Leader' by Everest Group in its assessment of our CTMS validates Oracle's mission to deliver cutting-edge technology that accelerates innovation and helps improve outcomes in life sciences," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "We are harnessing the full power of Oracle's expertise in data and AI to deliver platforms like CTMS, purpose-built to address the unique challenges of pharma and healthcare systems. Our solution is compliant, secure, cost-effective, and globally adaptable, empowering organizations to drive innovation and efficiency in clinical research and care delivery."
The evaluation highlights Oracle's strengths in providing a comprehensive solution to critical trial management and its abilities to accommodate diverse regulatory requirements globally. The report further highlights Oracle's competitive pricing and seamless integration with critical clinical systems, including EDC, Clinical Data Management Systems (CDMS), electronic trial master file (eTMF), payment, analytics, and regulatory systems.
"The CTMS market is rapidly evolving in response to growing trial complexity, the need for real-time collaboration, and diverse data sources' integration," said Nisarg Shah, practice director, Everest Group. "Providers are now delivering comprehensive trial data management solutions that offer enhanced features to elevate the quality of information provided."
"Oracle's Siebel CTMS platform offers a comprehensive, one-stop-shop solution for clinical trial management, providing flexibility for customization to meet specific organizational needs. Clients value the platform's seamless integration with various critical clinical systems and analytics solutions. Oracle's extensive global footprint, which helps deliver consistent operations across regions, combined with its expansive capabilities and competitive pricing have positioned Oracle as a Leader in the Life Sciences Clinical Trial Management System (CTMS) Products PEAK Matrix® Assessment 2024."
The Everest Group PEAK Matrix® is a proprietary framework for assessing the relative market success and overall capability of service providers based on performance, experiences, ability, and knowledge. Each service provider is comparatively assessed on two dimensions: market success and delivery capabilities. Market success is measured by revenue, number of clients, and year-over-year growth. Delivery capability is measured by scale of operations, scope, technology and innovation, delivery footprint, and buyer satisfaction. The resulting matrix categorizes service providers as Leaders, Major Contenders, and Aspirants.
To read the full Everest Group PEAK Matrix® report, visit: https://www.everestgrp.com/peak-matrix/healthcare-and-life-sciences/life-sciences-clinical-trial-management-system-ctms-products.html
To read about Oracle and the Everest Group PEAK Matrix® for Electronic Data Capture, visit: https://www.oracle.com/news/announcement/oracle-life-sciences-positioned-as-a-leader-in-the-everest-group-peak-matrix-for-electronic-data-capture-2024-10-24/
About Oracle Life Sciences
Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements – empowering the life sciences industry to improve patient outcomes. Learn more at oracle.com/lifesciences
About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.
Disclaimer
Licensed extracts taken from Everest Group's PEAK Matrix® Reports, may be used by licensed third parties for use in their own marketing and promotional activities and collateral. Selected extracts from Everest Group's PEAK Matrix® reports do not necessarily provide the full context of our research and analysis. All research and analysis conducted by Everest Group's analysts and included in Everest Group's PEAK Matrix® reports is independent and no organization has paid a fee to be featured or to influence their ranking. To access the complete research and to learn more about our methodology, please visit Everest Group PEAK Matrix® Reports.
About Everest Group
Everest Group is a leading global research firm helping business leaders make confident decisions. Everest Group's PEAK Matrix® assessments provide the analysis and insights enterprises need to make critical selection decisions about global services providers, locations, and products and solutions within various market segments. Likewise, providers of these services, products, and solutions, look to the PEAK Matrix® to gauge and calibrate their offerings against others in the industry or market. Find further details and in-depth content at www.everestgrp.com.
Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.
View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-recognized-as-a-leader-in-everest-group-peak-matrix-for-life-sciences-clinical-trial-management-system-ctms-assessment-2024-302365733.html
SOURCE Oracle
FAQ
What recognition did Oracle (ORCL) receive in the Everest Group PEAK Matrix Assessment 2024?
What are the key features of Oracle's Siebel CTMS platform highlighted in the 2024 assessment?
How does the Everest Group evaluate companies in their PEAK Matrix Assessment?
What competitive advantages of Oracle (ORCL) were highlighted in the 2024 CTMS assessment?
How is Oracle (ORCL) addressing the evolving needs of clinical trials according to the 2024 report?
